LivaNova (NASDAQ: LIVN) insider transactions
In the twelve months to 10 November 2026, executives and directors of LivaNova reported 7 open-market sales of 13,375 shares ($1.0m) and 0 open-market purchases, by 3 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 10 September 2026 | Bianchi Francesco | Director | Open-market sale | −3,500 | $78.01 | 4,434 | Form 4 |
| 4 September 2026 | Story Brooke | Director | Open-market sale | −2,300 | $81.42 | 7,488 | Form 4 |
| 31 August 2026 | Bianchi Francesco | Director | Open-market sale | −1,650 | $79.72 | 7,934 | Form 4 |
| 11 August 2026 | Tezel Ahmet | Chief Innovation Officer | Option exercise | +12,692 | $52.68 | 18,782 | Form 4 |
| 11 August 2026 | Tezel Ahmet | Chief Innovation Officer | Returned to the company | −8,589 | $77.86 | 10,193 | Form 4 |
| 11 August 2026 | Tezel Ahmet | Chief Innovation Officer | Shares withheld for tax | −1,428 | $77.86 | 8,765 | Form 4 |
| 11 August 2026 | Tezel Ahmet | Chief Innovation Officer | Open-market sale | −2,675 | $77.74 | 6,090 | Form 4 |
| 15 June 2026 | Zurbay Donald | Director | Option exercise | +2,560 | — | 2,560 | Form 4 |
| 15 June 2026 | Zurbay Donald | Director | Shares withheld for tax | −308 | $79.70 | 2,252 | Form 4 |
| 15 June 2026 | Story Brooke | Director | Option exercise | +4,042 | — | 10,274 | Form 4 |
| 15 June 2026 | Story Brooke | Director | Shares withheld for tax | −486 | $79.70 | 9,788 | Form 4 |
| 15 June 2026 | Enxing Seng Stacy | Director | Option exercise | +4,042 | — | 15,793 | Form 4 |
| 15 June 2026 | Enxing Seng Stacy | Director | Shares withheld for tax | −486 | $79.70 | 15,307 | Form 4 |
| 15 June 2026 | Kozy William A | Director | Option exercise | +5,681 | — | 38,248 | Form 4 |
| 15 June 2026 | Kozy William A | Director | Shares withheld for tax | −682 | $79.70 | 37,566 | Form 4 |
| 15 June 2026 | Tezel Ahmet | Chief Innovation Officer | Option exercise | +2,965 | — | 7,122 | Form 4 |
| 15 June 2026 | Tezel Ahmet | Chief Innovation Officer | Shares withheld for tax | −1,032 | $79.70 | 6,090 | Form 4 |
| 15 June 2026 | Barry James Christopher | Director | Option exercise | +4,042 | — | 8,404 | Form 4 |
| 15 June 2026 | Barry James Christopher | Director | Shares withheld for tax | −486 | $79.70 | 7,918 | Form 4 |
| 15 June 2026 | Podlogar Susan M | Director | Option exercise | +4,042 | — | 6,128 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the LivaNova page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.